Senseonics, Inc., a Germantown, MD-based developer of technology for glucose monitoring , received a $10m senior secured term loan.
California-based Metronom Health closed a $5.1 million funding round, with 5 unnamed investors so far, according to a regulatory filing.
Dallas, Texas-based virtual visits company Teladoc raised $50 million, according to an SEC filing. The round was led by Jafco Ventures with additional funding from FLAG Capital Management, Greenspring Associates, Mellon, and QuestMark Partners. This brings the company's total funding to about $96.6 million.
Rimidi received $1.3 million from the investors according to the SEC form registered.
San Francisco-based mobile-enabled health coaching services company Vida has raised $5 million in its first round of funding from Aspect Ventures, Khosla Ventures, Yahoo Co-Founder Jerry Yang, Signia Venture Partners, The Valley Fund, Yahoo Chairman Maynard Webb, Silicon Valley Bank's Kevin Scott, and Skip Battle.
The Israeli company CNoga Medical, developing a non-invasive diagnosis method for diabetes, completed a $12.5 million financing round from Chinese investment fund GoCapital. CNoga’s device uses the patient’s skin color to diagnose high blood pressure and a method for measuring blood sugar without puncturing the skin.
GlySens Incorporated announced today that it has been awarded a two-year, two million dollar grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a division of the National Institutes of Health (NIH). The grant is intended to support human clinical evaluation of the GlySens second generation ICGM™ long term implantable glucose monitoring system. Final preparations for launch of the trial are underway, and enrollment is expected to begin before the end of 2014.
San Diego-based GlySens says it has raised $12 million in Series C funding to advance its wireless technology for an implantable sensor that could be used to monitor blood sugar levels in people with diabetes. No investors were identified in the statement issued by GlySens, which says only that several new investors participated in the round, along with a group of existing investors.
Medtronic secured $6.2 million in a debt financing round according to the SEC form registered.
Welldoc registered a SEC form stating the funding of $4.2 million from the investors.